Tag: Constitutional challenges to drug price negotiations

In the coming months, the federal government plans to unveil the first ten drugs subject to Medicare’s historic price negotiations. However, pharmaceutical companies and their allies are actively working to impede these negotiations. Merck, the US Chamber of Commerce, and Bristol Myers Squibb have recently filed separate lawsuits against the government, arguing that Medicare’s authority…